{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:56:38Z","timestamp":1761155798734},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Program for the 12th Five-year Plan","award":["2012ZX10001003"],"award-info":[{"award-number":["2012ZX10001003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bbrc.2014.05.088","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T19:02:24Z","timestamp":1401217344000},"page":"202-207","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oxaliplatin antagonizes HIV-1 latency by activating NF-\u03baB without causing global T cell activation"],"prefix":"10.1016","volume":"450","author":[{"given":"Xiaoli","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanxian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huabiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanzhang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.05.088_b0005","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0140-6736(13)60104-X","article-title":"Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs","volume":"381","author":"Katlama","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2014.05.088_b0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The challenge of finding a cure for HIV infection","volume":"323","author":"Richman","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2014.05.088_b0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.molmed.2004.09.006","article-title":"The multifactorial nature of HIV-1 latency","volume":"10","author":"Lassen","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2014.05.088_b0020","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1189\/jlb.0403180","article-title":"Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells","volume":"74","author":"Rohr","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2014.05.088_b0025","doi-asserted-by":"crossref","first-page":"e11160","DOI":"10.1371\/journal.pone.0011160","article-title":"Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner","volume":"5","author":"Mehla","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.05.088_b0030","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1371\/journal.ppat.0030146","article-title":"HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K\/Akt and activates HIV transcription","volume":"3","author":"Contreras","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2014.05.088_b0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/MMBR.00011-06","article-title":"The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation","volume":"70","author":"Zhou","year":"2006","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bbrc.2014.05.088_b0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2174\/157016211798998736","article-title":"Control of HIV latency by epigenetic and non-epigenetic mechanisms","volume":"9","author":"Mbonye","year":"2011","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.bbrc.2014.05.088_b0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2012.12.008","article-title":"Targeting HIV latency: pharmacologic strategies toward eradication","volume":"18","author":"Xing","year":"2013","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.bbrc.2014.05.088_b0050","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(97)03358-8","article-title":"Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer","volume":"350","author":"L\u00e9vi","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2014.05.088_b0055","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/PL00012514","article-title":"Cellular and molecular aspects of drugs of the future: oxaliplatin","volume":"59","author":"Di Francesco","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2014.05.088_b0060","doi-asserted-by":"crossref","first-page":"e48832","DOI":"10.1371\/journal.pone.0048832","article-title":"Selective histone deacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB","volume":"7","author":"Ying","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.05.088_b0065","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.antiviral.2013.10.010","article-title":"As2O3 synergistically reactivate latent HIV-1 by induction of NF-\u03baB","volume":"100","author":"Wang","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbrc.2014.05.088_b0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.virol.2013.02.022","article-title":"Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation","volume":"440","author":"Ding","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2014.05.088_b0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/157016211796320333","article-title":"HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells","volume":"9","author":"Lin","year":"2011","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.bbrc.2014.05.088_b0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.onc.1206111","article-title":"P53-associated 3\u2032\u21925\u2032 exonuclease activity in nuclear and cytoplasmic compartments of cells","volume":"22","author":"Gila","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.05.088_b0085","doi-asserted-by":"crossref","first-page":"e6093","DOI":"10.1371\/journal.pone.0006093","article-title":"Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection","volume":"4","author":"Reuse","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.05.088_b0090","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1128\/JVI.78.19.10507-10515.2004","article-title":"Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue","volume":"78","author":"Biancotto","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.05.088_b0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/aid.2011.0263","article-title":"Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy","volume":"28","author":"Victoriano","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.bbrc.2014.05.088_b0100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.108.143826","article-title":"Chemotherapy-induced CXC-chemokine\/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of Nuclear Factor-\u03baB transcription and evasion of apoptosis","volume":"327","author":"Wilson","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2014.05.088_b0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cyto.2003.11.007","article-title":"Aspirin inhibits TNF\u03b1-and IL-1-induced NF-\u03baB activation and sensitizes HeLa cells to apoptosis","volume":"25","author":"Kutuk","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.bbrc.2014.05.088_b0110","first-page":"697","article-title":"Abnormal Nuclear Factor (NF)-\u03baB Signal Pathway and Aspirin Inhibits Tumor Necrosis Factor \u03b1\u2013Induced NF-\u03baB Activation in Keloid fibroblasts","volume":"33","author":"Zhu","year":"2007","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.bbrc.2014.05.088_b0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","article-title":"Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy","volume":"18","author":"Pierson","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2014.05.088_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-6-52","article-title":"\u201cShock and kill\u201d effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence","volume":"6","author":"Savarino","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.bbrc.2014.05.088_b0125","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.1128\/JVI.00793-12","article-title":"Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation","volume":"86","author":"Shishido","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.05.088_b0130","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1099\/0022-1317-77-9-1993","article-title":"Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels","volume":"77","author":"Moog","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbrc.2014.05.088_b0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-5002(01)00397-X","article-title":"Potential of 5-aza-2\u2032-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer","volume":"34","author":"Momparler","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbrc.2014.05.088_b0140","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.bcp.2007.12.004","article-title":"Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation","volume":"75","author":"M\u00e1rquez","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.05.088_b0145","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1128\/JVI.69.10.6572-6576.1995","article-title":"Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat","volume":"69","author":"Su\u00f1\u00e9","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.05.088_b0150","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/j.1460-2075.1993.tb06029.x","article-title":"A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation","volume":"12","author":"Perkins","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2014.05.088_b0155","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/157016210793499312","article-title":"Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency","volume":"8","author":"Perez","year":"2010","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.bbrc.2014.05.088_b0160","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1158\/0008-5472.CAN-08-4235","article-title":"Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer","volume":"69","author":"Banerjee","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.05.088_b0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/1535-7163.MCT-08-0659","article-title":"Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer","volume":"8","author":"Martinez-Card\u00fas","year":"2009","journal-title":"Mol. Cancer Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14009693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14009693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T06:04:45Z","timestamp":1597903485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14009693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0006291X14009693"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.05.088","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxaliplatin antagonizes HIV-1 latency by activating NF-\u03baB without causing global T cell activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.05.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}